(MENAFN- EIN Presswire) Immunohistochemistry Market
The global Immunohistochemistry Market size was valued at $2.4 billion in 2021, and is projected to reach $4.5 billion by 2031
PORTLAND, OR, UNITED STATES, July 12, 2023/einpresswire.com / -- The global immunohistochemistry industry generated $2.4 billion in 2021, and is expected to reach $4.5 billion by 2031, manifesting a CAGR of 6.5% from 2022 to 2031.
Immunohistochemistry (IHC) is a widely used laboratory technique that combines principles of immunology and histology to detect and visualize specific proteins or antigens within tissue samples. It allows researchers and pathologists to examine the spatial distribution and localization of target proteins in the context of cellular and tissue architecture.
📚 Download Sample PDF at
Impact of Covid-19 on Immunohistochemistry Market-
The immunohistochemistry market impacted positively during the Covid-19 pandemic, owing to surge in prevalence of Covid-19 infections and surge in the adoption of immunohistochemistry techniques for detecting Covid-19 infections.
According to a research published in the Laboratory Investigation journal in July 2020, the immunohistochemical (IHC) and in situ hybridization (ISH) assays were utilized for detecting Covid-19 infection.
The demand for immunohistochemistry techniques surged considerably among research organizations, hospitals, and universities to carry out tests and research activities to gather more information about Covid-19 infection and find out treatment options.
The antibody segment to maintain its leadership status during the forecast period
Based on product, the antibody segment accounted for the highest market share in 2021, contributing to more than two-fifths of the global immunohistochemistry market, and is projected to maintain its leadership status during the forecast period. Moreover, this segment is estimated to witness the highest CAGR of 7.3% from 2022 to 2031. This is due to increase in the use of primary and secondary antibodies in immunohistochemistry tests for the diagnosis of disease. The reagents segment is also projected to register a considerable growth rate throughout the forecast period, owing to rise in demand for advanced immunohistochemistry systems for clinical diagnosis. The research also offers a detailed analysis of segments including kits and equipment.
Procure Complete Report (200 Pages PDF with Insights, Charts, Tables, and Figures) @
The diagnosis segment to maintain its lead position during the forecast period
Based on application, the diagnosis segment contributed to the highest market share in 2021, holding nearly half of the global immunohistochemistry market, and is projected to maintain its lead position during the forecast period. Moreover, this segment is estimated to register the highest CAGR of 7.0% from 2022 to 2031. This is due to increase in the prevalence of various chronic diseases such as cancer and diabetes. On the other hand, the research segment is projected to grow at a considerable growth rate throughout the forecast period. This is due to increase in research & development activities by pharmaceutical companies for innovative drugs. The report also analyzes the forensic segment.
The hospital and diagnostic labs segment to maintain its leadership status by 2031
Based on end user, the hospital and diagnostic labs segment held the highest market share in 2021, accounting for nearly half of the global immunohistochemistry market, and is expected to maintain its lead status by 2031. Moreover, this segment is estimated to grow at the highest CAGR of 7.3% from 2022 to 2031. This is due to increase in prevalence of chronic diseases such as cancer, cardiovascular disease, heart disease, asthma, and chronic obstructive pulmonary disease along with rise in the number of patient visits. The research also analyzes the segments including research institutes and academic institutes and others.
Procure Complete Report at 20% Discount (258 Pages) :
North America to maintain its dominance in terms of revenue by 2031
Based on region, North America contributed the largest market share in 2021, accounting for around two-fifths of the global immunohistochemistry market, and is expected to maintain its dominance in terms of revenue by 2031. This is due to increase in the number of chronic disease cases, the presence of key players, and advancements in healthcare infrastructure in the region. However, Asia-Pacific is projected to manifest the fastest CAGR of 7.5% during the forecast period, owing to increase in medical tourism, implementation of new guidelines in Japan, surge in investments, and reforms to modernize China's healthcare infrastructure, and rapid growth of the healthcare industry in India. The research also analyzes regions including Europe and LAMEA.
Immunohistochemistry Market Key Players
Abcam PLC
Agilent Technologies Inc.
Becton, Dickinson & Company
Biocare Medical LLC
Biogenex Laboratories
Bio-Rad Laboratories Inc.
Cell Signaling Technology Inc.
Diagnostic Biosystems Inc.
Eagle Biosciences Inc.
Trending Reports in Healthcare Industry:
Central Lab Market Size:
Gene Synthesis Market Share:
Cell and gene supply chain services market Share:
Rare Disease Genetic Testing Market Size:
Contact:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
David Correa
Allied Analytics LLP
1 800-792-5285
email us here
Visit us on social media:
facebook
twitter
linkedin
Comments
No comment